{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:50:04Z","timestamp":1773867004459,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.clineuro.2011.05.007","type":"journal-article","created":{"date-parts":[[2011,6,27]],"date-time":"2011-06-27T15:39:50Z","timestamp":1309189190000},"page":"644-648","source":"Crossref","is-referenced-by-count":28,"title":["Levetiracetam compared to valproic acid: Plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage"],"prefix":"10.1016","volume":"113","author":[{"given":"S.","family":"Mink","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Muroi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Seule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bjeljac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2011.05.007_bib0005","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/01.nrl.0000195827.34370.63","article-title":"Management of seizures in the critically ill","volume":"12","author":"Varelas","year":"2006","journal-title":"Neurologist"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0010","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11940-007-0039-9","article-title":"Treatment of seizures in the neurologic intensive care unit","volume":"9","author":"Varelas","year":"2007","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0015","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1227\/00006123-199511000-00003","article-title":"Short-term perioperative anticonvulsant prophylaxis for the surgical treatment of low-risk patients with intracranial aneurysms","volume":"37","author":"Baker","year":"1995","journal-title":"Neurosurgery"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1227\/01.neu.0000279724.05898.e7","article-title":"Generalized convulsive status epilepticus after nontraumatic subarachnoid hemorrhage: the nationwide inpatient sample","volume":"61","author":"Claassen","year":"2007","journal-title":"Neurosurgery"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0025","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3171\/jns.2003.99.6.0978","article-title":"Characterization of perioperative seizures and epilepsy following aneurysmal subarachnoid hemorrhage","volume":"99","author":"Lin","year":"2003","journal-title":"J Neurosurg"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0030","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3171\/jns.2007.106.5.805","article-title":"Nonconvulsive status epilepticus in patients suffering spontaneous subarachnoid hemorrhage","volume":"106","author":"Little","year":"2007","journal-title":"J Neurosurg"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0035","doi-asserted-by":"crossref","DOI":"10.1111\/j.1528-1167.2007.01513.x","article-title":"Incidence of seizures in the acute phase of stroke: a population-based study","author":"Szaflarski","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0040","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/WNL.54.2.340","article-title":"Prevalence of nonconvulsive status epilepticus in comatose patients","volume":"54","author":"Towne","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0045","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3171\/JNS-07\/08\/0253","article-title":"Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs","volume":"107","author":"Rosengart","year":"2007","journal-title":"J Neurosurg"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0050","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1212\/WNL.55.9.1315","article-title":"Onset seizures independently predict poor outcome after subarachnoid hemorrhage","volume":"55","author":"Butzkueven","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0055","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1212\/01.WNL.0000038906.71394.DE","article-title":"Predictors and clinical impact of epilepsy after subarachnoid hemorrhage","volume":"60","author":"Claassen","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0060","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/01.STR.0000141936.36596.1e","article-title":"Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage","volume":"36","author":"Naidech","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0065","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1212\/WNL.55.2.258","article-title":"Anticonvulsant prophylaxis and timing of seizures after aneurysmal subarachnoid hemorrhage","volume":"55","author":"Rhoney","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0070","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1385\/NCC:5:2:85","article-title":"Specialized neurocritical care, severity grade, and outcome of patients with aneurysmal subarachnoid hemorrhage","volume":"5","author":"Lerch","year":"2006","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0075","first-page":"1185","article-title":"Status epilepticus and neuronal degeneration: of circuitries and vicious circles","volume":"2","author":"Rossetti","year":"2006","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF00644962","article-title":"Single and chronic dose pharmacokinetic studies of sodium valproate in epileptic patients","volume":"16","author":"Mihaly","year":"1979","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0085","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1528-1167.2006.00461.x","article-title":"Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA)","volume":"47","author":"Stefan","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0090","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/00007691-200312000-00007","article-title":"Serum concentrations of Levetiracetam in epileptic patients: the influence of dose and co-medication","volume":"25","author":"May","year":"2003","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0095","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2165\/00003088-200645110-00002","article-title":"Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?","volume":"45","author":"Johannessen","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0100","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1111\/j.1528-1167.2006.00819.x","article-title":"In situ metabolism of levetiracetam in blood of patients with epilepsy","volume":"47","author":"Patsalos","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0920-1211(02)00250-4","article-title":"Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials","volume":"53","author":"Perucca","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0110","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.clinthera.2006.05.004","article-title":"Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects","volume":"28","author":"Ramael","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0115","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/j.1528-1167.2006.00586.x","article-title":"Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study","volume":"47","author":"Ramael","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0120","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1528-1167.2006.00959.x","article-title":"Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures","volume":"48","author":"Baulac","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0163-7258(99)00052-2","article-title":"Pharmacokinetic profile of levetiracetam: toward ideal characteristics","volume":"85","author":"Patsalos","year":"2000","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0130","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2165\/00003088-200443110-00002","article-title":"Clinical pharmacokinetics of levetiracetam","volume":"43","author":"Patsalos","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0135","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00134-005-2695-0","article-title":"Pharmacokinetic interaction between valproic acid and meropenem","volume":"31","author":"Clause","year":"2005","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0140","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2710.2006.00743.x","article-title":"Epileptic seizures caused by low valproic acid levels from an interaction with meropenem","volume":"31","author":"Fudio","year":"2006","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0145","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1345\/aph.1K079","article-title":"Interaction between valproate and meropenem: a retrospective study","volume":"41","author":"Spriet","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0150","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1345\/aph.1M296","article-title":"The effect of carbapenem antibiotics on plasma concentrations of valproic acid","volume":"43","author":"Mancl","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clineuro.2011.05.007_bib0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1515\/DMDI.2009.24.2-4.153","article-title":"Valproic acid-carbapenem interaction: report of six cases and a review of the literature","volume":"24","author":"Tobin","year":"2009","journal-title":"Drug Metabol Drug Interact"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846711001405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846711001405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T20:56:44Z","timestamp":1543697804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846711001405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0303846711001405"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2011.05.007","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}